U.S. Markets closed

EyePoint Pharmaceuticals, Inc. (EYPT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
11.04+0.88 (+8.66%)
At close: 4:00PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2021)Next Year (2022)
No. of Analysts5555
Avg. Estimate-0.4-0.39-1.62-1.58
Low Estimate-0.47-0.47-1.77-2.5
High Estimate-0.36-0.31-1.48-1.09
Year Ago EPS-0.3-1.07-3.54-1.62
Revenue EstimateCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2021)Next Year (2022)
No. of Analysts5555
Avg. Estimate9.84M10.56M36.74M54.23M
Low Estimate9.3M9.5M35.2M50M
High Estimate10.3M11.4M38M59.5M
Year Ago Sales15.7M7.13M34.44M36.74M
Sales Growth (year/est)-37.30%48.10%6.70%47.60%
Earnings History9/29/202012/30/20203/30/20216/29/2021
EPS Est.-0.3-0.17-0.46-0.43
EPS Actual-0.3-1.07-0.5-0.35
Difference0-0.9-0.040.08
Surprise %0.00%-529.40%-8.70%18.60%
EPS TrendCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2021)Next Year (2022)
Current Estimate-0.4-0.39-1.62-1.58
7 Days Ago-0.4-0.39-1.62-1.58
30 Days Ago-0.43-0.42-1.73-1.61
60 Days Ago-0.43-0.4-1.73-1.45
90 Days Ago-0.43-0.4-1.73-1.45
EPS RevisionsCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2021)Next Year (2022)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days2221
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesEYPTIndustrySector(s)S&P 500
Current Qtr.-33.30%N/AN/AN/A
Next Qtr.63.60%N/AN/AN/A
Current Year54.20%N/AN/AN/A
Next Year2.50%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A